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Introduction: Urinary tract infections (UTIs) are one of the most frequent infections encountered by doctors. It can 
be a significant source of morbidity for some patients. Microbes are growing resistant to commonly prescribed 
antimicrobials and UTIs are becoming more difficult to treat day by day. The study aimed to investigate the 
common uropathogens encountered in our geographical region and to study their antibacterial susceptibility 
patterns. 
Material and Methods: It was a retrospective descriptive study carried out in the Armed Forces Institute of 
Urology, in collaboration with the Armed Forces Institute of Pathology, Rawalpindi, Pakistan, during the year 
2019. Positive reports for urine culture and sensitivity performed during the last two years were studied to 
document various isolates and their antimicrobial sensitivity. 
Results: A total of 3191 positive urine cultures in the last two years (2017-2019) were studied. Escherichia coli 
(66%), followed by Klebsiella Pneumonia (12%) were the most frequently encountered organisms. Overall 
resistance to Ciprofloxacin was 66%, Cotrimoxazole was 62%, Gentamycin was 40%, Fosfomycin (9.5%) followed 
by Meropenem (28%) and Nitrofurantoin (35%) were the most sensitive antibiotics. 
Conclusion: Gram-negative bacilli are the predominant organisms responsible for urinary tract infections. These 
uropathogens show significant resistance to routinely used antibiotics. Fosfomycin and Nitrofurantoin are 
suitable oral anti-bacterials for patients with UTI, whereas Meropenem is suitable if an injectable therapy is 
required. Our study may act as a guide for the choice of empiric antibiotics based on local resistant patterns. 















































Urinary tract infection (UTI) is one of the most 
commonly found diseases in medical practice today, 
with a significant proportion of the patient population 
found in almost all age groups.1 It is also emerging as 
one of the most common nosocomial infection, sharing 
a burden of up to 40% of all nosocomial infections.2 It 
is also responsible for 1.2% and 0.6% of all office visits 
by females and males respectively.3 UTI is an 
inflammatory process involving the urothelium due to 
bacterial invasion and usually comprises bacteriuria 
and pyuria.4 The criteria to label urinary tract infection 
is the existence of >105 bacteria/ml of urine in a 
midstream ‘clean catch’ urine specimen or from urine 
directly collected from a catheter.5 Bacteria may enter 
the urinary tract through the ascending, 
hematogenous, or lymphatic routes. The major 
reservoir for bacterial entry into the urinary tract is the 
bowel via passage through the urethra into the 
bladder.6,7 On the other hand, the hematogenous 
pathway is an uncommon route of kidney infection in 
normal individuals. Some unusual cases like severe 
bowel infection or retroperitoneal abscesses may cause 
the direct spread of bacteria from adjacent organs via 
the lymphatic route.8 
The best strategy to treat UTIs is by using empirical 
antibiotic therapy, the selection of antimicrobial agents 
should be based on the most likely pathogen involved, 
and its expected resistance pattern in a specific area.9 
Worldwide, many common bacteria including E.coli 
are becoming more prone to antimicrobial resistance.10 
Such resistance has also affected the sensitivity of 
uropathogens to antimicrobials owing to their 
excessive use. The knowledge and awareness of 
doctors regarding the prevalence and antimicrobial 
resistance of uropathogens is the need of the hour.11 As 
common organisms are becoming more and more 
resistant to the routinely prescribed antibiotics, it is 
very important to address the prescribing habits of 
doctors of this era. It is becoming harder to treat 
infections with every passing day, and this may 
eventually lead to therapeutic dead ends.12 
The purpose of this study is to register commonly 
encountered uropathogens along with their 
antimicrobial sensitivities. This information will not 
only help doctors understand the sensitivity pattern of 
common antimicrobials prescribed to treat urinary 
tract infections but also help improve the empirical 
treatment of patients. 
 
Materials and Methods 
 
All 3191, midstream ‘clean catch’ or catheter 
specimens with positive cultures during the study 
period were included in the study. The specimens 
were collected in sterilized wide mouth, leak-proof 
plastic containers of 20 ml capacity. Specimens were 
processed in the Microbiology Lab as soon as possible. 
The urine samples were inoculated on culture plates 
by a semi-quantitative method of urine analysis 
whereby, a fixed quantity of 0.2 microliters of urine 
from each specimen was applied on culture media. 
The culture media used were CLED agar (Cysteine, 
Lactose, Electrolyte Deficient) and Blood agar. The 
culture plates were incubated aerobically at 37°C for a 
minimum of 18 hours and a maximum of 48 hours. 
Culture plates were examined for growth after 18 
hours of incubation. Positive cultures have proceeded 
for identification and negative cultures were re 
incubated to be examined again after 48 hours before 
reporting as No Growth. Those Cultures were taken 
positive which yielded growth equal to or greater than 
20 CFU (Colony forming units) of a single isolate 
whereas, cultures yielding Mixed growth were 
disregarded. The isolates were identified using 
biochemical methods and API (analytical profile 
index) strips. Antibiotic Sensitivity was done by Disc 
Diffusion Method using Mueller Hinton agar 
supplemented with 5% sheep blood. Zone diameters 
were interpreted after 18 hours of incubation at 37*C 
according to CLSI (Clinical Laboratory Standard 
Institute) guidelines. Where necessary identification 
and sensitivity were confirmed by using an automated 




Positive urine culture and sensitivity reports of 3191 
urine samples submitted to the laboratory of Armed 
Forces Institute of Pathology, Rawalpindi in two years 
(July 2017-June 2019) were studied retrospectively. 
Most common isolate was E.coli (66.3%) followed by 
Klebsiella (11.5%). Isolates are listed in Table 1. 
Currently, seven antibiotics are tested in routine use to 
determine the sensitivity of common uropathogens. 
Fosfomycin followed by Meropenem and 
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Table 1: Microorganisms isolated from patients with UTI’s 
Organism Positive Cultures Percentage 
Escherichia coli 2116 66 
Klebsiella pneumonia 369 12 
Enterococcus species 285 9 
Pseudomonas aeruginosa 197 6 
Enterobacter species 113 4 
Proteus species 111 3 
 





Enterococcus  Pseudomonas 
aeruginosa 
Enterobacter Proteus 
Ciprofloxacin 76 64 79 75 53 51 
Nitrofurantoin 9 57 25 NT 50 NT 
Fosfomycin 3 16 7 NT 12 NT 
Ceftriaxone 69 63 NT                   IR 57 53 
Meropenem 12 33 NT          60 28 9 
Gentamycin 34 36 NT         53 32 46 
Cotrimoxazole 67 57 NT                   IR 47 78 




Our study aimed to determine the most commonly 
encountered uropathogens in clinical practice along 
with their antibiotic susceptibilities. To ensure early 
and effective treatment of the infection, recent updates 
on antibiotic resistance patterns is important for timely 
modification of drug of choice for empirical therapy.13 
Even though the uropathogens remain the same over 
time but they have developed increasing levels of 
resistance to easily available and less expensive 
antibiotics. 
Gram-negative uropathogens have shown higher 
isolation rates (>90%) than gram-positive organisms 
(<10%) in many studies. E. coli is still considered the 
main uropathogen that causes UTIs while the 
prevalence of K. pneumonia and Enterococcus spp. 
has increased over the years.14,15,16 Our data also 
revealed that gram-negative organisms like E. coli are 
still the most frequently isolated uropathogen (66%) 
followed by Klebsiella pneumoniae (12%). The high 
incidence of E. coli is mainly due to the fact that it is a 
part of the normal flora of the bowel and infection is 
mostly via fecal route accompanied by poor hygiene. 
A study conducted by Chiu et al16 in Taiwan in 2016 
showed Escherichia coli to be the most commonly 
isolated organism (54.5%), followed by Klebsiella 
pneumonia (13.1%), a finding concurrent with our 
study. The study showed the highest rate of antibiotic 
susceptibility with ceftriaxone (71.4%), cefepime 
(94.5%), amikacin (97.5%), and gentamycin (76.1%). 
On the other hand, our study showed the highest 
resistance rates to Ciprofloxacin (66%), Cotrimoxazole 
(62%), Ceftriaxone (61%), and Gentamycin (40%). The 
development of antibiotic resistance in a specific 
geographical area is highly dependent on antibiotic 
prescription habits. Another study conducted by Naz 
et al17 in 2018 in Lahore, Pakistan showed the highest 
isolation rates of Escherichia coli (60.5%) and 
Klebsiella pneumonia (26.3%). This study was 
conducted in the paediatric population but still 
showed similar findings to our study which was 
conducted in the adult population.  
Another study carried out by Setu et al18 in Dhaka, 
Bangladesh in 2015 showed the highest isolation rates 
of Escherichia coli and Klebsiella pneumonia in gram-
negative species and S. aureus in gram-positive 
species. The highest levels of antibiotic resistance were 
found to Amoxicillin (77%), Nalidixic acid (63%), and 
Ceftriaxone (56%). Our study also revealed similar 
findings for antibiotic resistance to ceftriaxone. In 
another study carried out in the southwest of Iran in 
2012 by Valavi et al19, similar findings were revealed 
as our study with Escherichia coli (84%) and Klebsiella 
pneumonia (10.1%) the most frequently isolated 
pathogens. Nitrofurantoin emerged as the most 
effective antibiotic in this study; a finding concurrent 
to our study. Nitrofurantoin has demonstrated 
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significant efficacy in many studies in the past. It has 
emerged as a good therapeutic option for 
uncomplicated cystitis in the United States and in 
some southern European countries, where 
fluoroquinolones and co-trimoxazole isolates from 
urine have shown high resistance rates.20 
Another study carried out by Obiofu et al21 in Nigeria 
in 2018, differed from our study as Staphylococcus 
aureus (47.2%) was the predominant isolate, followed 
by E.coli (20.2%) and Klebsiella (15.7%). The study 
showed the highest susceptibility rate of gram-
negative organisms to Nitrofurantoin. Variation in 
isolated organisms might be due to the difference in 
the geographical distribution of the pathogens. Our 
results were further supported by a study carried out 
by Mitiku et al22 in Ethiopia in 2017 where E.coli 
emerged as the predominant gram-negative 
uropathogen (55%), followed by Klebsiella spp (16.3%) 
and Proteus species (12.2%). This study showed 
Nitrofurantoin (100%) and Ciprofloxacin (92%) as the 
most effective antibiotics for E.coli. Nitrofurantoin also 
proved to be effective for E.coli in our study (91%). On 
the contrary, Ciprofloxacin did not show considerable 
efficacy (24%) in our study. In another study 
conducted by Lakshminarayana et al23 in India in 2015, 
the most common isolate was E.coli (66.5%) followed 
by Klebsiella Pneumoniae (14.3%). Similar to our 
study, Meropenem and Nitrofurantoin were amongst 
the most sensitive antibiotics in this study.  
Other antibiotics did not show significant sensitivity 
rates thus limiting their use as empirical therapy. It 
was interesting to note that the once frequently 
prescribed Quinolones and Ceftriaxone have now 
developed a significant level of resistance. Increasing 
levels of resistance can be due to poor sterilization 
techniques and disinfection practices and not 
following appropriate WHO guidelines for 
implementation of the antibiotic remedy. The 
similarities and differences in the distribution of 
uropathogens may exist due to difference in 
environmental conditions and host factors, healthcare 
awareness, socioeconomic standards, and hygiene 
practices in each country.24 Recently, fosfomycin has 
also proven to be beneficial for the treatment of 
infections with multidrug-resistant uropathogens; a 
finding also supported by our study.25 
Our study has certain limitations. Firstly, it was a 
single centre study, further multi-centric studies are 
required to assess the resistance patterns of various 
antibiotics in our setup. Secondly, we did not perform 
phenotypic testing nor genotypic testing of bacterial 
enzymes as a cause of antibiotic resistance. Thirdly, we 
did not include the distribution of patients based on 
the source of infection like nosocomial, community-
acquired, or catheter-associated to further categorize 




Urinary tract infections are considered to be one of the 
most common infections encountered by humans. The 
most frequent uropathogens are gram-negative bacilli 
which demonstrate significant resistance to routinely 
prescribed antibiotics. The choice of antimicrobial 
therapy is directed by the knowledge of antibiotic 
sensitivity till the arrival of culture and sensitivity 
reports. Fosfomycin, Nitrofurantoin, and Meropenem 
are suitable options for empirical therapy as they have 
the least resistance. 
Management of urinary tract infections may improve 
by continued surveillance of antibiotic resistance and 
antibiotic prescription patterns of doctors and 
evolving antibiotic guidelines for urinary tract 
infections to slow down the fast-developing resistant 




1. A Singhal, R Sharma, M Jain, and L Vyas. Hospital and 
Community Isolates of Uropathogens and their Antibiotic 
Sensitivity Pattern from a Tertiary Care Hospital in North West 
India. Ann Med Health Sci Res. 2014 Jan-Feb; 4(1): 51–56. DOI: 
10.4103/2141-9248.126611 
2. Szasz M, Lehotkai N, Kristóf K, Szabó D, Nagy K. Prevalence 
and antimicrobial resistance of uropathogens in different 
inpatient wards. Acta Microbiol Immunol Hung. 2009;56:375–
87. DOI: 10.1556/amicr.56.2009.4.7 
3. Hansel DE, McKenney JK, Stephenson AJ, Chang SS. The 
Urinary Tract: A Comprehensive Guide to Patient Diagnosis and 
Management, New York: Springer; 2012. 64 p DOI: 
10.1007/978-1-4614-5320-8 
4. Mittal S, Kumar A, Govil N, Urinary tract infections: General 
considerations. SM Journals, Dec 2015.  DOI: 
10.5005/jp/books/18034_9  
5. Stark RP, Maki DG. Bacteriuria in a catheterized patient. N 
Eng J Med 1984; 311:560–4. DOI: 
10.1056/NEJM198408303110903 
6. Hickling DR, SUN TT and WU XR. Anatomy and Physiology 
of the Urinary Tract: Relation to Host Defense and Microbial 
Infection. Microbiol Spectr. 2015 Aug; 3(4): 
10.1128/microbiolspec.UTI-0016-2012. DOI: 
10.1128/9781555817404.ch1 
7. Kucheria R, Dasgupta P, Sacks SH, et al Urinary tract 
infections: new insights into a common problem Postgraduate 
Medical Journal 2005;81:83-86. DOI: 
10.1136/pgmj.2004.023036 
8. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. 
Infections of the urinary tract. In: Wein AJ, editor. Campbell-
Walsh Urology. 10th edition. Philadelphia: Elsevier; 2012. 261 p  
DOI: 10.1111/j.1749-771X.2007.00017.x 
310                                                                             Journal of Rawalpindi Medical College (JRMC); 2020; 24(4): 306-310 
9. Alabi AS, Frielinghaus L, Kaba H, Koster K, Huson MA, Kahl 
BC, et al. Retrospective analysis of antimicrobial resistance and 
bacterial spectrum of infectionin Gabon, Central Africa. BMC 
Infect Dis. 2013;13:455. DOI:10.1186/1471-2334-13-455 
10. Tahir Hameed, Abdullah Al Nafeesah, Syed Chishti, 
Mohammed Al Shaalan, and Khaled Al Fakeeh. Community-
acquired urinary tract infections in children: Resistance patterns 
of uropathogens in a tertiary care center in Saudi Arabia. Int J 
Pediatr Adolesc Med. 2019 Jun; 6(2): 51–54. DOI: 
10.1016/j.ijpam.2019.02.010 
11. Khan S, Ahmed A. Uropathogens and their susceptibility 
patterns; A retrospective analysis. J Pak Med Assoc 
2005;51(2):98–100.  
12. Moroh JLA, Fleury Y, Tia H, et al. Diversity and antibiotic 
resistance of uropathogenic bacteria from Abidjan. Afr J Urol. 
2014;20:18–24. DOI: 10.1016/j.afju.2013.11.005 
13. Niranjan V, Malini A. Antimicrobial resistance pattern in 
Escherichia coli causing urinary tract infection among inpatients. 
Indian J Med Res. 2014;139:945–8. DOI:  
2014/139/6/945/138080 
14. Farrell DJ, Morrissey I, De Rubies D, Robbins M, Felmingham 
D. A UK Multicentre study of the antimicrobial susceptibility of 
bacterial pathogens causing urinary tract infection. J Infect 
2003;46(2):94–100. DOI: 10.1053/jinf.2002.1091 
15. Ahmed NH, Raghuraman K, Baruah FK, Grover RK. 
Antibiotic Resistance Pattern of Uropathogens: An Experience 
from North Indian Cancer Patient. J Glob Infect Dis. 
2015;7(3):113–115. DOI: 10.4103/0974-777x.161742 
16. Chiu CC, Lin TC, Wu RX, Yang YS, Hsiao PJ, Lee Y, Lin JC, 
Chang FY. Etiologies of community-onset urinary tract infections 
requiring hospitalization and antimicrobial susceptibilities of 
causative microorganisms. Journal of Microbiology, Immunology 
and Infection. 2017 Dec 1;50(6):879-85. DOI: 
10.1016/j.jmii.2016.08.008 
17. Naz Z, Batool A, Rauf A. High resistance in uropathogens 
isolated from children at Pakistani hospital. Journal of University 
Medical & Dental College. 2018 Apr 3;9(1):26-32. 
18. Setu SK, Sattar AN, Saleh AA, Roy CK, Ahmed M, 
Muhammadullah S, Kabir MH. Study of Bacterial pathogens in 
Urinary Tract Infection and their antibiotic resistance profile in a 
tertiary care hospital of Bangladesh. Bangladesh Journal of 
Medical Microbiology. 2016;10(1):22-6. DOI: 
10.3329/bjmm.v10i1.31449 
19. Valavi E, Nikfar R, Ahmadzadeh A, Kompani F, Najafi R, 
Hoseini R. The last three years antibiotic susceptibility patterns of 
uropathogens in southwest of Iran. DOI: 10.5812/jjm.4958. 
20. Duława J. Urinary tract infection-2003. Rocz Akad Med 
Bialymst. 2004;49:182-4. 
21. Obiofu EN, Ige OH, Iroro O. Antimicrobial susceptibility 
pattern of urinary isolates from outpatients suspected for urinary 
tract infection. GSC Biological and Pharmaceutical Sciences. 
2018;5(3):001-11.DOI: 10.30574/gscbps.2018.5.3.0124 
22. Mitiku SY. Bacterial uropathogens and their antibiotic 
susceptibility pattern at Dessie regional health laboratory. J 
Microbiol Biotechnol Res. 2017;3:1-9. DOI: 
10.3390/molecules22081255 
23. Lakshminarayana SA, Chavan SK, Prakash R, Sangeetha S. 
Bacterial pathogens in urinary tract infection and antibiotic 
susceptibility pattern from a Teaching Hospital, Bengaluru, India. 
Int J Curr Microbiol Appl Sci. 2015;4(11):731-6. 
24. Shaifali I, Gupta U, Mahmood SE, Ahmed J. Antibiotic 
susceptibility patterns of urinary pathogens in female outpatients. 
North American journal of medical sciences. 2012 Apr;4(4):163. 
DOI: 10.4103/1947-2714.94940 
25. Michalopoulos AS, Livaditis IG, Gougoutas V. The revival of 
fosfomycin. International journal of infectious diseases. 2011 Nov 
1;15(11):e732-9. DOI: 10.1016/j.ijid.2011.07.007 
